학술논문
Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trial
Document Type
Article
Author
Source
In Blood Advances 14 November 2023 7(21):6441-6450
Subject
Language
ISSN
2473-9529